These results are consistent with those obtained in another study in which two automated immunological assays (the Abbott SARS-CoV-2 IgG CLIA and the EUROIMMUN anti-SARS-CoV-2 IgG/IgA ELISA) and a lateral flow immunoassay (the LFIA NG IgG-IgG COVID-19 test) were performed, with the results showing sensitivity for IgG detection of 100.0% in all trials. Here, CD79A is linked to COVID-19.